
Amneal Pharmaceuticals Investor Relations Material
Latest events

Q2 2025
Amneal Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Amneal Pharmaceuticals Inc
Access all reports
Amneal Pharmaceuticals, Inc. is a pharmaceutical company engaged in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. The company offers a wide range of dosage forms, including oral solids, injectables, and topicals, addressing therapeutic areas such as central nervous system disorders, oncology, and cardiovascular conditions. The company is headquartered in Bridgewater, New Jersey, and its shares are listed on the NYSE.
Key slides for Amneal Pharmaceuticals Inc


Q3 2024
Amneal Pharmaceuticals Inc


Q1 2025
Amneal Pharmaceuticals Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
AMRX
Country
🇺🇸 United States